SCHEMBL19242566

SCHEMBL19242566

Nc1nc(Cl)nc2c1ncn2C1CCC(CO)O1

nearest known ligand 0.70

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.65
PDE4D Q08499 2/20 0.65
PDE3A Q14432 2/20 0.65
PNP P00491 1/20 0.65
TP53 P04637 1/20 0.65
HTT P42858 1/20 0.65
SMN1; SMN2 Q16637 1/20 0.65
RXFP1 Q9HBX9 1/20 0.65
ALDH1A1 P00352 1/20 0.57
ALB P02768 1/20 0.57
MAPK1 P28482 1/20 0.57
ADORA3 P0DMS8 8/20 0.55
ADORA2A P29274 3/20 0.55
ADORA1 P30542 2/20 0.55
PDE2A O00408 1/20 0.55
ADRA1A P35348 1/20 0.55
CYP1A2 P05177 1/20 0.53
HSP90AA1 P07900 1/20 0.50
HSP90B1 P14625 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30694424 1.00 LMNA (0.65) LMNAPDE4DPDE3APNPTP53
SCHEMBL8124562 1.00 LMNA (0.65) LMNAPDE4DPDE3APNPTP53
SCHEMBL172618 1.00 LMNA (0.65) LMNAPDE4DPDE3APNPTP53
SCHEMBL13770324 0.89 PDE4D (0.57) LMNAPDE4DPDE3APNPTP53
SCHEMBL23585882 0.88 LMNA (0.57) LMNAPDE4DPDE3APNPTP53
SCHEMBL25712959 0.88 LMNA (0.59) LMNAPDE4DPDE3APNPTP53
SCHEMBL3239663 0.88 LMNA (0.59) LMNAPDE4DPDE3APNPTP53
SCHEMBL9601136 0.87 LMNA (0.55) LMNAPDE4DPDE3APNPTP53
SCHEMBL7435133 0.87 LMNA (0.58) LMNAPDE4DPDE3APNPTP53
SCHEMBL9601706 0.86 LMNA (0.57) LMNAPDE4DPDE3APNPTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023178128-A1 METHODS OF TREATING MEDICAL CONDITIONS USING ISLATRAVIR OR A RELATED COMPOUND ROME THERAPEUTICS, INC. (US) 2023-09-21 WO disclosed
EP-3505527-A1 CYCLIC DINUCLEOTIDES FOR CYTOKINE INDUCTION Invivogen (FR) 2019-07-03 EP disclosed
EP-2752422-B1 Stereoselective synthesis of phosphorus containing actives GILEAD PHARMASSET LLC (US) 2017-08-16 EP disclosed
CN-101668768-A Preparation A2A-adenosine receptor agonists and polymorphs thereof CV THERAPEUTICS INC 2010-03-10 CN disclosed